Ligand validation:6KYA

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6KYA_NAG_A_907	69%	56%	0.141	0.955	0.56	1.11	-	1	0	0	100%	1
6KYA_NAG_A_902	37%	23%	0.171	0.868	0.58	2.51	-	3	0	0	100%	1
6KYA_NAG_A_915	31%	53%	0.247	0.916	0.59	1.22	-	2	0	0	100%	1
6KYA_NAG_B_916	19%	46%	0.239	0.837	0.48	1.56	-	3	0	0	100%	1
6KYA_NAG_A_916	18%	57%	0.274	0.863	0.77	0.9	1	1	0	0	100%	1
6KYA_NAG_B_902	16%	38%	0.336	0.912	0.7	1.7	-	4	0	0	100%	1
6KYA_NAG_B_907	16%	53%	0.288	0.855	0.54	1.24	-	1	0	0	100%	1
6KYA_NAG_B_915	6%	45%	0.4	0.844	0.63	1.48	-	3	0	0	100%	1
3WN4_NAG_A_902	95%	40%	0.057	0.96	0.85	1.46	-	3	1	0	100%	1
4R0A_NAG_A_917	95%	19%	0.059	0.96	1.39	2.05	2	4	1	0	100%	1
5WYX_NAG_A_914	94%	35%	0.059	0.957	0.85	1.7	-	3	0	0	100%	1
4QC0_NAG_A_905	93%	53%	0.058	0.954	0.52	1.27	-	2	0	0	100%	1
3W3G_NAG_A_1013	93%	29%	0.062	0.957	0.86	1.97	1	5	0	0	100%	1
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	1
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	1
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	1
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	1
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.